Alison M. Michie, PhD

Professor in Molecular Lymphopoiesis
University of Glasgow, United Kingdom

N/A

Poster(s):

• 1205 - Investigating the eEF2K/eEF2 axis as a potential target in CLL following nelfinavir treatment

• 1206 - Subversion of ERK-MAPK-mediated mRNA translation elongation as a therapeutic strategy in CLL